Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
20 participants
INTERVENTIONAL
2025-12-09
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post-Market Clinical Follow-up (PMCF) Study of the Pitch-Patch for the Augmentation or Reinforcement of the Rotator Cuff
NCT05906004
Pilot Study to Evaluate the Restore Orthobiologic Implant in Rotator Cuff Tear Repair
NCT00208338
Pilot Study of Therapy With Hylan G-F 20 Exercise Capacity
NCT01810848
ARTEBONE Bone Void Filler in Arthrodesis Procedure of the Ankle
NCT02480868
Novel Gallium 68 Citrate in Orthopedic Infections
NCT03123289
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Voll Degradable Shoulder Spacer
Voll Degradable Shoulder Spacer
Voll Degradable Shoulder Spacer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Voll Degradable Shoulder Spacer
Voll Degradable Shoulder Spacer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or female patients ≥ fifty (50) years of age, in general good health, independent, and can comply with all post-operative evaluations and visits.
Exclusion Criteria
* Concurrent participation in any other investigational clinical study.
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Voll Medical Technologies Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assuta Ashdod Hospital
Ashdod, , Israel
Ichilov (Sourasky Medical Center)
Tel Aviv, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
053CLD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.